Numbers

Figures converted from INR at historical FX rates — see fx_rates.json for the rate table. Ratios, margins, and multiples are unitless and unchanged.

The Numbers

Gopal Snacks trades at an optically absurd 800+ trailing P/E because FY2025 earnings collapsed to near zero. But that collapse was a one-off fire and raw-material shock, not a broken business. The single metric most likely to rerate the stock: whether operating margins return to double digits over the next two quarters. If they do, this thesis flips from "overpriced disaster" to "cyclical recovery still cheaply priced." If they don't, the premium multiple has zero floor.

Snapshot

Revenue is roughly stable at $16–17 million but earnings have swung from $1.3 million (FY23) to $0.22 million (FY25) to TTM $0.04 million. The balance sheet is clean with negligible debt. The P/E is sky-high because the denominator is missing — not because the business has a moat premium.

Revenue & Earnings Power

Revenue has compounded at roughly 11% annually since FY2020, but operating margins collapsed from a peak of 14% in FY2023 to 7% in FY2025. FY2023 was the standout year — margin expansion driven by raw-material tailwinds that reversed sharply. The business can grow top-line; the question is whether it can sustain margins above 10%.

Quarterly revenue shows a seasonal peak in Q2/Q3 (festive demand) but the recovery from the Q4 FY25 trough ($3.71 M) to $4.46 M in Q3 FY26 is real. The business is not shrinking.

Cash Generation — Are the Earnings Real?

Cash conversion has been volatile. In FY25, operating cash of $0.80 M exceeded net income ($0.22 M) because of non-cash charges including the insurance write-down. Over the trailing five years, cumulative CFO is $4.15 M against cumulative net income of $3.61 M — a decent conversion ratio of about 114%. Free cash flow turned negative in FY25 due to a step-up in capex ($0.96 M), partly rebuilding after the fire. The balance sheet can absorb this; net debt is trivial.

Capital Allocation

Dividends started only post-IPO and remain modest ($0.15 M in FY25 against net income of $0.22 M, implying a 66% payout of a depressed number). Capex ramped in FY25 — management has guided for capacity expansion. No buybacks. The capital-allocation story is simple: reinvest for growth, return a token dividend, carry no meaningful debt.

Balance Sheet Health

The balance sheet has deleveraged dramatically — from over 1.0x D/E in FY21 to 0.17x in FY25. Borrowings of $0.76 M are minuscule against equity of $4.73 M. CRISIL rates the company A/Stable. There is no solvency risk.

Valuation — Now vs Peers

Because Gopal Snacks listed only in March 2024, a 20-year valuation history isn't meaningful. Instead, the relevant question is: how does the market price Gopal relative to the businesses it competes against?

Gopal's P/E of 65x (on FY25 EPS, not TTM) sits between Bikaji (65x) and Prataap (222x), but its ROCE of 16% is well below Bikaji's 20% and Britannia's 57%. The market is pricing Gopal as if margins will rapidly recover and growth will reaccelerate — a bet that has not yet materialised in the numbers.

Fair Value & Scenario

Without a statistical fair-value estimate, we frame value around recovery assumptions:

• Bear ($2.13 / -26%): Margins stay depressed at 5%, FY26 revenue $17.3 M, net profit $0.27 M => P/E ~110x on TTM. Multiple compresses to 40x on tiny earnings → $2.13.
• Base ($3.41 / +18%): 10% EBITDA margin on $18.9 M, net profit $0.78 M => P/E 48x. Markets continue to pay 45–50x for the branded snacks recovery story.
• Bull ($4.80 / +66%): EBITDA margin recovers to 13%, revenue hits $21.2 M, net profit $1.34 M => P/E 37x, in line with Bikaji's current multiple.

The range is wide because the denominator is currently tiny. The next two quarterly results will determine which scenario the market anchors to.

Closing

The numbers confirm that Gopal Snacks' underlying business — a scalable branded snacks franchise with $16+ M revenue, clean balance sheet, and expanding distribution — is intact. What the numbers contradict is the popular narrative that this stock is a "dead money" post-IPO. The FY25 profit collapse was a one-time fire event, and the quarterly revenue recovery from Q4 FY25 to Q3 FY26 suggests the demand engine is alive. The key watch for the next quarter is whether the sequential margin recovery (from 1% in Q4 FY25 to 8% in Q3 FY26) continues through Q4 FY26 and into FY27. If it does, the current share price will look like a coiled spring. If it stalls, the premium valuation will be unwound rapidly.